IL-Y, a synthetic member of the IL-12 cytokine family, suppresses the development of type 1 diabetes in NOD mice

European Journal of Immunology

Volumn 45, Issue 11, 2015, Pages 3114-3125

  Flores, Rafael R ^a   Kim, Eun ^b   Zhou, Liqiao ^a   Yang, Chenjie ^c   Zhao, Jing ^a   Gambotto, Andrea ^b,c   Robbins, Paul D ^a,c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adenovirus; Interleukin 12; NOD mice; Regulatory T cells; Type 1 diabetes

Indexed keywords

ADENOVIRUS VECTOR; GAMMA INTERFERON; HETERODIMER; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 35; STAT3 PROTEIN;

ARTICLE; AUTOIMMUNE DISEASE; BIOLOGICAL ACTIVITY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; TUMOR GROWTH; ADENOVIRIDAE; ANIMAL; ANTIGEN PRESENTATION; C57BL MOUSE; DISEASE MODEL; FEMALE; FLOW CYTOMETRY; GENE INACTIVATION; GENE VECTOR; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE;

ADENOVIRIDAE; ANIMALS; ANTIGEN PRESENTATION; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; GENE KNOCKOUT TECHNIQUES; GENETIC VECTORS; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, INBRED NOD;

EID: 84951567126     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201445403     Document Type: Article

References (51)

1. Vignali, D. A.and Kuchroo, V. K., IL-12 family cytokines: immunological playmakers. Nat. Immunol. 2012. 13: 722-728.
2. Chen, L.and Flies, D. B., Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 2013. 13: 227-242.
3. Lewis, K. L.and Reizis, B., Dendritic cells: arbiters of immunity and immunological tolerance. Cold Spr. Harb. Persp. Biol. 2012. 4: a007401.
4. Manicassamy, S.and Pulendran, B., Dendritic cell control of tolerogenic responses. Immunol. Rev. 2011. 241: 206-227.
5. Collison, L. W.and Vignali, D. A., Interleukin-35: odd one out or part of the family? Immunol. Rev. 2008. 226: 248-262.
6. Hall, A. O., Silver, J. S.and Hunter, C. A., The immunobiology of IL-27. Adv. Immunol. 2012. 115: 1-44.
7. Hunter, C. A.and Kastelein, R., Interleukin-27: balancing protective and pathological immunity. Immunity 2012. 37: 960-969.
8. + T cells through Stat1-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. 2003. 100: 15047-15052.
9. Yoshimoto, T., Yoshimoto, T., Yasuda, K., Mizuguchi, J.and Nakanishi, K., IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation. J. Immunol. 2007. 179: 4415-4423.
10. Awasthi, A., Carrier, Y., Peron, J. P., Bettelli, E., Kamanaka, M., Flavell, R. A., Kuchroo, V. K.et al., A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 2007. 8: 1380-1389.
11. Fitzgerald, D. C., Zhang, G. X., El-Behi, M., Fonseca-Kelly, Z., Li, H., Yu, S., Saris, C. J.et al., Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 2007. 8: 1372-1379.
12. Stumhofer, J. S., Silver, J. S., Laurence, A., Porrett, P. M., Harris, T. H., Turka, L. A., Ernst, M.et al., Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 2007. 8: 1363-1371.
13. Niedbala, W., Wei, X. Q., Cai, B., Hueber, A. J., Leung, B. P., McInnes, I. B.and Liew, F. Y., IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur. J. Immunol. 2007. 37: 3021-3029.
14. Collison, L. W., Pillai, M. R., Chaturvedi, V.and Vignali, D. A., Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J. Immunol. 2009. 182: 6121-6128.
15. + regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J. Immunol. 2010. 184: 7144-7153.
16. Gambotto, A., Tuting, T., McVey, D. L., Kovesdi, I., Tahara, H., Lotze, M. T.and Robbins, P. D., Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12. Can. Gene Ther. 1999. 6: 45-53.
17. Reay, J., Gambotto, A.and Robbins, P. D., The antitumor effects of adenoviral-mediated, intratumoral delivery of interleukin 23 require endogenous IL-12. Can. Gene Ther. 2012. 19: 135-143.
18. Reay, J., Kim, S. H., Lockhart, E., Kolls, J.and Robbins, P. D., Adenoviral-mediated, intratumor gene transfer of interleukin 23 induces a therapeutic antitumor response. Can. Gene Ther. 2009. 16: 776-785.
19. Bhalla, K., Tang, C., Ibrado, A. M., Grant, S., Tourkina, E., Holladay, C., Hughes, M.et al., Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells. Blood 1992. 80: 2883-2890.
20. Lee, A. Y., Chung, H. K., Bae, E. K., Hwang, J. S., Sung, B. W., Cho, C. W., Kim, J. K.et al., A recombinant human G-CSF/GM-CSF fusion protein from E. coli showing colony stimulating activity on human bone marrow cells. Biotech. Lett. 2003. 25: 205-211.
21. Lieschke, G. J., Rao, P. K., Gately, M. K.and Mulligan, R. C., Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo. Nat. Biotech. 1997. 15: 35-40.
22. Watford, W. T., Hissong, B. D., Bream, J. H., Kanno, Y., Muul, L.and O'Shea, J. J., Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 2004. 202: 139-156.
23. Anderson, M. S.and Bluestone, J. A., The NOD Mouse: A model of immune dysregulation. Annu. Rev. Immunol. 2005. 23: 447-485.
24. Atkinson, M. A., The pathogenesis and natural history of type 1 diabetes. Cold Spr. Harb. Persp. Med. 2012. 2: a007641.
25. + T cells with limited suppressor activity. Eur. J. Immunol. 2011. 41: 1480-1490.
26. Grinberg-Bleyer, Y., Baeyens, A., You, S., Elhage, R., Fourcade, G., Gregoire, S., Cagnard, N.et al., IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J. Exp. Med. 2010. 207: 1871-1878.
27. Tang, Q., Adams, J. Y., Penaranda, C., Melli, K., Piaggio, E., Sgouroudis, E., Piccirillo, C. A.et al., Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 2008. 28: 687-697.
28. Michels, A. W.and Eisenbarth, G. S., Immune intervention in type 1 diabetes. Sem. Immunol. 2011. 23: 214-219.
29. Shoda, L. K., Young, D. L., Ramanujan, S., Whiting, C. C., Atkinson, M. A., Bluestone, J. A., Eisenbarth, G. S.et al., A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 2005. 23: 115-126.
30. Maurer, M.and von Stebut, E., Macrophage inflammatory protein-1. Intern. J. Biochem. Cell Biol. 2004. 36: 1882-1886.
31. Ramos, C. D., Canetti, C., Souto, J. T., Silva, J. S., Hogaboam, C. M., Ferreira, S. H.and Cunha, F. Q., MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4. J. Leuko. Biol. 2005. 78: 167-177.
32. Schlecker, E., Stojanovic, A., Eisen, C., Quack, C., Falk, C. S., Umansky, V.and Cerwenka, A., Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth. J. Immunol. 2012. 189: 5602-5611.
33. Gee, K., Guzzo, C., Che Mat, N. F., Ma, W.and Kumar, A., The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflam. Aller. Drug Targ. 2009. 8: 40-52.
34. Pflanz, S., Hibbert, L., Mattson, J., Rosales, R., Vaisberg, E., Bazan, J. F., Phillips, J. H.et al., WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 2004. 172: 2225-2231.
35. Yoshida, H.and Miyazaki, Y., Regulation of immune responses by interleukin-27. Immunol. Rev. 2008. 226: 234-247.
36. Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately, M. K.and Adorini, L., Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 1995. 181: 817-821.
37. Trembleau, S., Penna, G., Gregori, S., Giarratana, N.and Adorini, L., IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma. J. Immunol. 2003. 170: 5491-5501.
38. Trembleau, S., Penna, G., Gregori, S., Magistrelli, G., Isacchi, A.and Adorini, L., Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes. J. Immunol. 2000. 165: 6748-6755.
39. Bettini, M., Castellaw, A. H., Lennon, G. P., Burton, A. R.and Vignali, D. A., Prevention of autoimmune diabetes by ectopic pancreatic beta-cell expression of interleukin-35. Diabetes 2012. 61: 1519-1526.
40. Cao, Y., Doodes, P. D., Glant, T. T.and Finnegan, A., IL-27 induces a Th1 immune response and susceptibility to experimental arthritis. J. Immunol. 2008. 180: 922-930.
41. Hibbert, L., Pflanz, S., DeWaal Malefyt, R.and Kastelein, R. A., IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J. Interf. Cyto. Res. 2003. 23: 513-522.
42. Takeda, A., Hamano, S., Yamanaka, A., Hanada, T., Ishibashi, T., Mak, T. W., Yoshimura, A.et al., Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 2003. 170: 4886-4890.
43. Villarino, A. V., Stumhofer, J. S., Saris, C. J., Kastelein, R. A., deSauvage, F. J.and Hunter, C. A., IL-27 limits IL-2 production during Th1 differentiation. J. Immunol. 2006. 176: 237-247.
44. Wojno, E. D., Hosken, N., Stumhofer, J. S., O'Hara, A. C., Mauldin, E., Fang, Q., Turka, L. A.et al., A role for IL-27 in limiting T regulatory cell populations. J. Immunol. 2011. 187: 266-273.
45. Wang, R. X., Yu, C. R., Mahdi, R. M.and Egwuagu, C. E., Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells. J. Biol. Chem. 2012. 287: 36012-36021.
46. Yoshida, H., Hamano, S., Senaldi, G., Covey, T., Faggioni, R., Mu, S., Xia, M.et al., WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 2001. 15: 569-578.
47. Gao, W., Rzewski, A., Sun, H., Robbins, P. D.and Gambotto, A., UpGene: Application of a web-based DNA codon optimization algorithm. Biotech. Prog. 2004. 20: 443-448.
48. Bilbao, R., Reay, D. P., Hughes, T., Biermann, V., Volpers, C., Goldberg, L., Bergelson, J.et al., Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors. Gene Ther. 2003. 10: 1821-1829.
49. Flores, R. R., Zhou, L.and Robbins, P. D., Expression of IL-2 in beta cells by AAV8 gene transfer in pre-diabetic NOD mice prevents diabetes through activation of FoxP3-positive regulatory T cells. Gene Ther. 2014. 21: 715-722.
50. Freer, G.and Rindi, L., Intracellular cytokine detection by fluorescence-activated flow cytometry: basic principles and recent advances. Methods 2013. 61: 30-38.
51. Krutzik, P. O., Trejo, A., Schulz, K. R.and Nolan, G. P., Phospho flow cytometry methods for the analysis of kinase signaling in cell lines and primary human blood samples. Meth. Molec. Biol. 2011. 699: 179-202.